Main
>
ONCOLOGY (**)
>
Lymphoma>NHL>B-Cell>DLBCL***
>
1st Line TREAT.:
>
USA. G. CD79B Marker Inhibitor+
>
(*) USA Approval Date: 2023. 04.19
(*) USA Approval Date: 2023. 04.19's products
This section has no products